HEALTHMay 28 · 10:34 UTCSCMP CHINAReuters

France becomes first EU country to reimburse anti-obesity drugs

France becomes the first EU country to reimburse anti-obesity drugs like Wegovy and Mounjaro for severely obese patients starting mid-June. The policy, announced by Health Minister Stephanie Rist, is estimated to cost the state €100 million annually.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

FranceplaceStephanie RistpersonNovo NordiskorganizationEli LillyorganizationWegovytopicMounjarotopicEuropean Unionorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 28 · 08:06 UTC
France to partially reimburse weight-loss drugs for obesity patients
HEALTHApr 14 · 11:00 UTC
US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises
HEALTHMay 6 · 09:00 UTC
A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
HEALTHMay 28 · 10:45 UTC
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
HEALTHMay 12 · 13:25 UTC
STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more
HEALTHMay 6 · 10:00 UTC
A new Medicare option for weight loss drugs is coming: Here's what to know